Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in...
Monotherapy with the PCSK9 inhibitor alirocumab versus ezetimibe in patients with hypercholesterolemia: Results of a 24week, double-blind, randomized Phase 3 trial.
Effects of Lowering LDL Cholesterol on Progression of Kidney Disease.
Lowering LDL cholesterol reduces the risk of developing atherosclerotic events in CKD, but the effects of such treatment on progression of kidney disease remain uncertain.
New Findings from Cleveland Clinic Update Understanding of...
Statin intolerance, which is predominantly due to muscle-related side effects, is reported in up to 10% to 20% of patients."
Impact of Drug Policy on Regional Trends in Ezetimibe Use [Original Articles]
From the Department of Pharmacy Practice and Administration, College of Pharmacy, Western University of Health Sciences, Pomona, CA ; Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA ; Department of Medicine, Section of Cardiovascular Medicine and Center for Outcomes Research and Evaluation, Yale New Haven Hospital , Yale ... (more)
Which diet is the right diet?
Dear Dr. Roach: I am taking Zetia and niacin for extremely high cholesterol and triglycerides.
Why are doctors still prescribing Zetia?
A health research company just released a list of the 100 top drugs in America according to sales.
Merck Says It Regrets Strong-Arming Italian Researcher
Merck says that it "regrets" using legal threats to push a leading Italian researcher to muffle his public critiques of one of the company's cholesterol drugs.
Merck Uses Legal Threats To Stifle Negative Advice About Zetia And Vytorin In Italy
In response to repeated legal threats, a public health doctor in Italy has withdrawn advice to curtail use of a controversial drug.